Application of unsupervised and supervised machine learning approaches to blood-based biomarkers of Alzheimer’s disease in a memory clinic cohort
Blood-based biomarkers (BBMs) are promising tools to facilitate biological diagnosis of Alzheimer’s Disease (AD). Establishing reliable cutoffs for BBMs represents a major issue for real-world implementation and the investigation of combined BBM approaches is limited. Our aim is to test different machine learning...